What is China Biologic Products Holdings EPS without NRI?
China Biologic Products Holdings's earnings per share without non-recurring items for the
three
months ended in Sep. 2020 was $0.99.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2020 was $3.58.
During the past 12 months, China Biologic Products Holdings's average earnings per share (NRI) Growth Rate was -12.30% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was -1.90% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was 3.20% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 30.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for China Biologic Products Holdings's EPS without NRI or its related term are showing as below:
CBPO'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -12.9 Med: 19.35 Max: 153
Current: -1.9
During the past 13 years, China Biologic Products Holdings's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 153.00% per year. The lowest was -12.90% per year. And the median was 19.35% per year.
CBPO's 3-Year EPS without NRI Growth Rate is not ranked
in the Biotechnology industry.
Industry Median: 5.3
vs CBPO: -1.90
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
China Biologic Products Holdings EPS without NRI Chart
Competitive Comparison of China Biologic Products Holdings's EPS without NRI
For the Biotechnology subindustry, China Biologic Products Holdings's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Biologic Products Holdings's PE Ratio without NRI Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, China Biologic Products Holdings's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where China Biologic Products Holdings's PE Ratio without NRI falls into.
China Biologic Products Holdings EPS without NRI Calculation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.58
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Biologic Products Holdings (NAS:CBPO) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
China Biologic Products Holdings EPS without NRI Related Terms
Thank you for viewing the detailed overview of China Biologic Products Holdings's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.
China Biologic Products Holdings (China Biologic Products Holdings) Business Description
China Biologic Products Holdings Inc is a biopharmaceutical company principally engaged in the research, development, manufacturing and sales of human plasma-based products in China. The company operates its business through two majority owned subsidiaries, Shandong Taibang and Guizhou Taibang. China Biologic's product pipeline includes a variety of dosages across multiple product categories. Its principal products are human albumin and immunoglobulin for intravenous injection. All of the company's products are prescription medicines administered in the form of injections. China Biologic's sales model focuses on direct sales to hospitals and inoculation centers and is complemented by distributor sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CBPO has been successfully added to your 